Intelligence · Patents
Patents expiring in 2043
Annual patent cliff calendar for 2043 — US pharmaceutical patents by expiration date.
- Patents
- 1,718
Quick answer
1,718 indexed pharmaceutical patents have expiration dates in 2043. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 11690921
Delivery of target specific nucleases
granted -
US 11690853
Non-hormonal steroid modulators of NF-κβ for treatment of disease
granted -
US 11690894
Transgenic corn with antifungal peptide AGM182 (DN:0113.18)
granted -
US 11691972
Compounds for targeted degradation of BRD9
granted -
US 11691992
Oxaborole analogs and uses thereof
granted -
US 11692032
Anti-LAG3 antibodies and uses thereof
granted -
US 11691987
Bicyclic heterocyclyl derivatives as IRAK4 inhibitors
granted -
US 11691948
Crystalline freebase forms of a biphenyl compound
granted -
US 11690919
Endolysosomal targeting conjugates for improved delivery of cargo molecules to the endolysosomal compartment of target cells
granted -
US 11690901
Southern cattle tick vaccine product
granted -
US 11691974
3,9-diazaspiro[5,5]undecane compound as FLT3 and AXL inhibitors
granted -
US 11690850
Inhibitors of receptor interacting protein kinase I for the treatment of disease
granted -
US 11690895
Compositions and methods of interferon alpha binding proteins
granted -
US 11690827
Methods for treating ocular Demodex using lotilaner formulations
granted -
US 11691011
Pain-relieving apparatus
granted -
US 11692030
Biomarkers and methods for detection of seizures and epilepsy
granted -
US 11692176
Halogenation of complex organic compounds
granted -
US 11690825
20-HETE receptor (GPR75) antagonists and methods of use
granted -
US 11690933
Absorbent aliphatic polyurethane foam product
granted -
US 11692018
TGF-β polypeptides
granted -
US 11692229
Fast diagnosis and personalized treatments for acne
granted -
US 11690920
General and direct method for preparing oligonucleotide-functionalized metal-organic framework nanoparticles
granted -
US 11693015
Methods of treating patients afflicted with irritable bowel syndrome, inflammatory bowel disease or chronic gastrointestinal functional disorders based on assessment of intestinal barrier function
granted -
US 11690898
Adeno-associated virus Factor VIII vectors, associated viral particles and therapeutic formulations comprising the same
granted -
US 11690915
Ras inhibitors
granted -
US 11690851
Methods and compositions comprising ursolic acid and/or resveratrol for treating diabetes, or cancer
granted -
US 11690918
Pyrrolobenzodiazepine-anti-CD22 antibody conjugates
granted -
US 11692184
Thermostable RNA-guided endonucleases and methods of use thereof
granted -
US 11690826
Methods for treating demodex blepharitis using lotilaner formulations
granted -
US 11690836
Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
granted -
US 11690829
Use of gaboxadol for the treatment of non-24 hour sleep-wake disorder
granted -
US 11690839
Treatment of idiopathic pulmonary fibrosis
granted -
US 11690860
Treatment of HCV infected patients with cirrhosis
granted -
US 11690837
Methods of improving cell-based therapy
granted -
US 11696896
Immunomodulatory nanoparticle treatment of brain injury
granted -
US 11696903
Compounds and methods for scavenging dicarbonyl electrophiles
granted -
US 11696922
Nanoparticle to target cancer
granted -
US 11696898
Halogenated ether compounds and methods of inducing anesthesia
granted -
US 11696956
Bicyclic peptide ligands specific for EphA2
granted -
US 11696904
Prodrug for therapeutic applications
granted -
US 11696893
Preparation comprising vonoprazan
granted -
US 11697667
Salts and polymorphs of cethromycin for the treatment of disease
granted -
US 11697639
Quaternary ammonium salt compound, preparation method therefor and use thereof
granted -
US 11697648
Fused pyrimidine pyridinone compounds as JAK inhibitors
granted -
US 11699503
Methods of identifying and treating patient populations amenable to cancer immunotherapy
granted -
US 11697689
Use of antibody against O-acetylated GD2 ganglioside to improve the therapeutic potential of drugs
granted -
US 11697669
Hemi-citrate salts of GABA-A positive allosteric modulator and crystalline form thereof
granted -
US 11696933
HLA-restricted VCX/Y peptides and T cell receptors and use thereof
granted
Frequently asked questions
How many pharma patents expire in 2043?
1,718 published patents in our USPTO index have expiration dates falling in calendar year 2043.